Accupril Generics Come Off The Market Following Preliminary Injunction
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva and Ranbaxy plan to appeal the district court ruling in favor of Pfizer to the federal appeals court. Pfizer said it will seek damages for lost Accupril sales since the December launch of Teva/Ranbaxy’s quinapril.